Stock Track | DaVita HealthCare Partners Plunges 5.26% After-Hours as Full-Year Guidance Misses Estimates Despite Q2 Beat

Stock Track

Aug 05

Shares of DaVita HealthCare Partners (DVA) tumbled 5.26% in after-hours trading on Tuesday, following the release of its second-quarter 2026 financial results and a weaker-than-expected full-year earnings outlook.

The company reported adjusted earnings per share of $4.02 for the second quarter, surpassing the IBES estimate of $3.88. Revenue came in at $3,554 million, beating the consensus estimate of $3,496 million. However, the positive quarterly performance was overshadowed by DaVita's guidance for fiscal 2026. The company expects adjusted EPS to range between $14.10 and $15.20, with the midpoint of $14.65 falling short of the FactSet consensus estimate of $14.88.

The disappointing guidance, which fell below analyst expectations, triggered the stock's decline in extended trading, as investors focused on the softer earnings outlook rather than the strong quarterly results.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1120274650"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120274650\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120274650?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120274650","market":"nz","top_or_hot":-1,"title":"Stock Track | DaVita HealthCare Partners Plunges 5.26% After-Hours as Full-Year Guidance Misses Estimates Despite Q2 Beat","media":"Stock Track","content":"<p>Shares of DaVita HealthCare Partners (DVA) tumbled 5.26% in after-hours trading on Tuesday, following the release of its second-quarter 2026 financial results and a weaker-than-expected full-year earnings outlook.</p>\n<p>The company reported adjusted earnings per share of $4.02 for the second quarter, surpassing the IBES estimate of $3.88. Revenue came in at $3,554 million, beating the consensus estimate of $3,496 million. However, the positive quarterly performance was overshadowed by DaVita's guidance for fiscal 2026. The company expects adjusted EPS to range between $14.10 and $15.20, with the midpoint of $14.65 falling short of the FactSet consensus estimate of $14.88.</p>\n<p>The disappointing guidance, which fell below analyst expectations, triggered the stock's decline in extended trading, as investors focused on the softer earnings outlook rather than the strong quarterly results.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DaVita HealthCare Partners Plunges 5.26% After-Hours as Full-Year Guidance Misses Estimates Despite Q2 Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DaVita HealthCare Partners Plunges 5.26% After-Hours as Full-Year Guidance Misses Estimates Despite Q2 Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-05 04:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of DaVita HealthCare Partners (DVA) tumbled 5.26% in after-hours trading on Tuesday, following the release of its second-quarter 2026 financial results and a weaker-than-expected full-year earnings outlook.</p>\n<p>The company reported adjusted earnings per share of $4.02 for the second quarter, surpassing the IBES estimate of $3.88. Revenue came in at $3,554 million, beating the consensus estimate of $3,496 million. However, the positive quarterly performance was overshadowed by DaVita's guidance for fiscal 2026. The company expects adjusted EPS to range between $14.10 and $15.20, with the midpoint of $14.65 falling short of the FactSet consensus estimate of $14.88.</p>\n<p>The disappointing guidance, which fell below analyst expectations, triggered the stock's decline in extended trading, as investors focused on the softer earnings outlook rather than the strong quarterly results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1120274650","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120274650","pubTimestamp":1785875585,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of DaVita HealthCare Partners (DVA) tumbled 5.26% in after-hours trading on Tuesday, following the release of its second-quarter 2026 financial results and a weaker-than-expected full-year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"股票跟踪 | DaVita HealthCare Partners 盘后股价暴跌 5.26%，尽管第二季度表现强劲，但全年指引未达预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"Shares of DaVita HealthCare Partners (DVA) tumbled 5.26% in after-hours trading on Tuesday, following the release of its second-quarter 2026 financial results and a weaker-than-expected full-year earnings outlook.\nThe company reported adjusted earnings per share of $4.02 for the second quarter, surpassing the IBES estimate of $3.88. Revenue came in at $3,554 million, beating the consensus estimate of $3,496 million. However, the positive quarterly performance was overshadowed by DaVita's guidance for fiscal 2026. The company expects adjusted EPS to range between $14.10 and $15.20, with the midpoint of $14.65 falling short of the FactSet consensus estimate of $14.88.\nThe disappointing guidance, which fell below analyst expectations, triggered the stock's decline in extended trading, as investors focused on the softer earnings outlook rather than the strong quarterly results.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}